Clowes Howard

Track

Insider profile

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 55% 68% 82%
Transactions
7 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Clowes Howard's trades of Plus Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
16.14
Quantity 40,929 +5.9%
Value US$4,898,884
Transaction date
Purchase
Price
479.10
Quantity 74,764 +34.4%
Value US$1,610,271
Transaction date
Purchase
Price
67.47
Quantity 3,727 -30.6%
Value US$4,522,305
Transaction date
Purchase
Price
3.98
Quantity 1,000 +27.0%
Value US$3,980
Transaction date
Purchase
Price
3.64
Quantity 2,500 +208.3%
Value US$9,102
Transaction date
Purchase
Price
0.57
Quantity 15,000 +500.0%
Value US$8,589
Transaction date
Purchase
Price
2.42
Quantity 3,000 +inf%
Value US$7,260
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-13 2024-09-11
B Purchase
40,929 +5.9%
16.14
US$4,898,884 		40,929 +5.9% 16.14 US$4,898,884
2024-05-10 2024-05-08
B Purchase
74,764 +34.4%
479.10
US$1,610,271 		74,764 +34.4% 479.10 US$1,610,271
2023-09-15 2023-09-13
B Purchase
3,727 -30.6%
67.47
US$4,522,305 		3,727 -30.6% 67.47 US$4,522,305
2023-06-08 2023-06-06
B Purchase
1,000 +27.0%
3.98
US$3,980 		1,000 +27.0% 3.98 US$3,980
2023-05-04 2023-05-03
B Purchase
2,500 +208.3%
3.64
US$9,102 		2,500 +208.3% 3.64 US$9,102
2022-06-06 2022-06-02
B Purchase
15,000 +500.0%
0.57
US$8,589 		15,000 +500.0% 0.57 US$8,589
2021-03-04 2021-03-03
B Purchase
3,000 +inf%
2.42
US$7,260 		3,000 +inf% 2.42 US$7,260